Introduction {#Sec1}
============

Injury is the major cause of death in adults younger than 45 years of age \[[@CR1]\]. The implementation of trauma systems and dedicated level I trauma centres in the United States has reduced mortality of severely injured patients, usually defined as patients with an Injury Severity Score (ISS) above 15, and improved functional outcome at discharge \[[@CR2]\]. In 2012, Regional Trauma Networks with Major Trauma Centre hubs (MTC) were implemented in the English National Health Service - early mortality changes were not found in the immediate post-implementation period \[[@CR3]\]. But a recent paper suggests a 19% case fatality reduction over the 5 years since MTC designation \[[@CR4]\]. Commissioning and formal designation of Major Trauma Centres was done at national rather than regional level to create uniformity in service provision and equity of access.

Implicit to the centralization of trauma care is the idea that increased volumes of severely injured patients lead to more experienced health care providers, which could result in improved patient outcomes. A recently published systematic review showed that higher hospital volume is associated with lower mortality in severely injured patients \[[@CR5]\]. However, hospitals treating severely injured patients do not only differ in hospital volume. Other factors, such as variation in case mix, organization of care, facilities and geographic location could cause between-centre differences. For example, in the field of traumatic brain injury (TBI) considerable between-centre differences have been found, \[[@CR6]--[@CR9]\] but it is still unknown how these are caused. It remains unclear if between-centre outcome differences for severely injured patients exist between major centres and whether they could be explained by differences in hospital volume.

Therefore, the aim of this study was to determine whether there is an association between hospital volume of severely injured patients and patient outcomes in Major Trauma centres (MTCs).

Patients and methods {#Sec2}
====================

Data {#Sec3}
----

A retrospective observational cohort study was performed using the Trauma Audit and Research Network (TARN) database. TARN is a national trauma registry including all patients with major trauma admitted to hospitals in England and Wales. The TARN includes all patients with significant injury who were admitted for at least 72 h, or to an high-dependency area or who died following arrival at hospital. TARN has UK Health Research Authority Approval (PIAG Section 251) for research on anonymised patient data.

In this study, all patients with an ISS \> 15, admitted to an English MTC or transferred to an English MTC between 1 January 2013 and 31 December 2016 were selected from the TARN database. The STROBE statement was used when reporting the data.

Outcomes {#Sec4}
--------

The primary outcome variable was in-hospital mortality. The secondary outcome variables were length of stay (LOS), critical care LOS, time from arrival at the Emergency Department (ED) to first operation and time from arrival at ED to first CT scan.

Statistical analysis {#Sec5}
--------------------

First, between-centre differences in in-hospital mortality were assessed using a random effects logistic regression model. The first model only contained a random intercept for centre, so the outcome of the patient was only based on the centre that treated the patient. The variance of the random effects was expressed as tau-squared. If tau-squared is above 1, it suggests substantial heterogeneity between centres. Also, the between-centre differences were expressed in a 95% range of odds ratios for each centre compared to the average centre \[[@CR10]\].

Second, hospital volume was calculated for every MTC as the mean number of severely injured patients treated in one MTC per year. To assess the volume-outcome relationship, observed mortality rates were plotted against hospital volume for all MTCs. For the purpose of description of patient characteristics hospital volume was divided in tertiles.

Subsequently multivariable random effects logistic regression (in-hospital mortality) and linear regression (LOS, critical care LOS, time to first operation and time to first CT scan) models were used to analyse the effect of volume on outcome. Hospital volume was tested for nonlinearity using splines and Likelihood Ratio Test. Both the unadjusted and adjusted models contained hospital volume and a random intercept for centres. The adjusted models were based on clinically relevant confounders including age, sex, ISS, Revised Trauma Score (RTS), Charlson Comorbidity Index (CCI), penetrating injury, Abbreviated Injury Score (AIS) head injury and referral \[[@CR11]\]. ISS was modelled with a spline function and an interaction term was added for the relationship between the effect of age and the effect of sex in accordance with the TARN model \[[@CR12]\]. A sensitivity analysis included all patients directly transferred to a MTC. An extra sensitivity analysis was done using the new injury severity score (NISS) \> 15 as criterium for severely injury, since NISS is more sensitive for head injury \[[@CR13]\].

Statistical analyses were performed in R statistical software 3.4.2 (R Foundation for Statistical Computation, Vienna). Random effect models were fitted with Adaptive Gaussian Quadrature with 15 qpoints using the lme4 package.

Results {#Sec6}
=======

Descriptives {#Sec7}
------------

A total of 47,159 severely injured patients were included in this study. These patients were admitted to 28 MTCs, with volumes varying from 69 to 781 severely injured patients per year. Median age was 53 (Interquartile Range (IQR) 32--74), 70.1% of the patients were male and median ISS was 25 (17--29) (Table [1](#Tab1){ref-type="table"}). The median Glasgow Coma Score (GCS) at the Emergency Department was 15 (IQR 14--15). Table 1Baseline characteristicsTotal\
*N* = 47,157Tertile 1,\
volume ≤ 490,\
*N* = 16,280Tertile 2,\
volume 491--574, *N* = 15,573Tertile 3,\
volume \> 574,\
*N* = 15,304Number of MTCs281486Age53 (32--74)56 (36--76)52 (31--72)53 (31--73)Male33,072 (70.1%)11,224 (68.9%)11,056 (71.0%)10,792 (70.5%)Penetrating injury1364 (2.9%)404 (2.5%)543 (3.5%)417 (2.7%)ISS25 (17--29)25 (17--27)25 (18--29)25 (18--29)NISS34 (25--50)34 (25--50)34 (26--50)34 (26--50)GCS at arrival Emergency Department15 (14--15)15 (13--15)15 (14--15)15 (14--15)Charlson Comorbidity Index0 (0--3)0 (0--4)0 (0--3)0 (0--4)Intubation at Emergency Department12,256 (26.0%)3837 (23.6%)4313 (27.7%)4106 (26.8%)Hypovolemic shock at Emergency Department (SBP \< 90 mmHg)8662 (18.4%)2757 (16.9%)3203 (20.6%)2702 (17.7%)AIS head ≥330,258 (64.2%)10,409 (63.9%)9822 (63.1%)10,027 (65.5%)RTS7.84 (7.6--7.84)7.8 (7.6--7.84)7.8 (7.6--7.84)7.8 (7.8--7.84)Referred patients15,118 (32.1%)5194 (31.9%)4577 (29.4%)5347 (34.9%)Length of Stay10 (5--21)10 (5--20)11 (5--21)10 (5--22)Critical Care Length of Stay0 (0--3)0 (0--3)0 (0--4)0 (0--3)In-hospital mortality5876 (12.5%)2047 (12.6%)1937 (12.4%)1892 (12.4%)Continuous: median (IQR), categorical: N (%), New Injury Severity Score (NISS), Injury Severity Score (ISS), Abbreviated Injury Scale (AIS), Revised Trauma Score (RTS), Glasgow Coma Score (GSC)

In total 5876 patients died in-hospital (12.5%), the median LOS was 10 days (IQR 5--21) and the median critical care LOS was 0 days (IQR 0--3, Table [1](#Tab1){ref-type="table"}). Volume was divided in tertiles (first tertile: hospital volume ≤ 490, *N* = 16,280, second tertile: hospital volume 491--574, *N* = 15,573, third tertile: hospital volume \> 574, *N* = 15,304). There were no variation in baseline characteristics between the tertiles (Table [1](#Tab1){ref-type="table"}).

Between-Centre differences {#Sec8}
--------------------------

The observed mortality rates varied from 4.7 to 15.0% (Fig. [1](#Fig1){ref-type="fig"}), but the random-effects model showed the true differences to be very small (in-hospital mortality tau-squared = 0.015). The 95% odds ratio range of centre effects was 0.97--1.03 (Table [2](#Tab2){ref-type="table"}, Fig. [2](#Fig2){ref-type="fig"}a). After adjustment for patient characteristics, the between-centre differences decreased (tau-squared = 0.006) with a corresponding 95% range of centre effects of 0.99--1.01. This means that the odds of dying in the lowest percentile of centres (2.5th) was 0.99 times the average, while the odds of dying in the highest percentile of centres (97.5th) was 1.01 times the average (Fig. [2](#Fig2){ref-type="fig"}b). Fig. 1Forrest plot with observed mortality rates per MTC. Red line: fitted unadjusted linear regression model for the association between mortality rates and hospital volume with corresponding 95% Confidence IntervalsTable 2Between- centre differences for in-hospital mortalityTau^2^95% centre RangeUnadjusted0.0150.97--1.03Adjusted0.0060.99--1.01Adjusted including volume0.0040.99--1.01Fig. 2Differences in mortality rates between centres. Unadjusted differences between centers, log odds of 0 indicates average mortality, lines indicate 95% posterior interval. Differences between centers, adjusted for age, gender, age\*gender, ISS (spline), RTS, Charlson Comorbidity Index, penetrating injury, AIS head injury and referred patients

Volume-outcome relationship: in-hospital mortality {#Sec9}
--------------------------------------------------

There was a non-significant association between higher hospital volume and higher in-hospital mortality according to the unadjusted random effects model (OR 1.63 per 10 patients, 95% CI 0.98--2.71, *p* = 0.06, Table [3](#Tab3){ref-type="table"}). After adjustment, there was no association between hospital volume and in-hospital mortality (OR 1.02, 95%CI 0.68--1.54, *p* = 0.92). Also, after excluding referred patients there was no significant association between hospital volume and in-hospital mortality (OR 0.71, 95% CI 0.41--1.22, *p* = 0.21). Hospital volume was considered linear (*p*-value of nonlinear term = 0.89), so no cut-off could be found. Using NISS \> 15 as criterium for severely injured, found similar results (adjusted OR: 1.01, 95% 0.64--1.60, *p* = 0.96, [Appendix](#Sec13){ref-type="sec"}). Table 3Unadjusted and adjusted coefficients of hospital volume for different outcome measures, expressed as odds ratio or beta per 10 patientsOutcomeOR per 10 patients95% CIP-value**In-hospital mortality** Unadjusted OR1.630.98--2.710.06 Adjusted\* OR1.020.68--1.540.92 Adjusted\* OR excluding referred patients0.710.41--1.220.21**Beta per 10 patientsLength of stay (days)** Unadjusted β0.05−0.01-0.110.11 Adjusted\* β0.03− 0.03-0.090.33 Adjusted\* β excluding referred patients0.070.00--0.140.06**Critical care length of stay (days)** Unadjusted β0.20−0.25-0.650.39 Adjusted\* β−0.02−2.84-2.800.93 Adjusted\* β excluding referred patients0.480.02--0.940.04**Time to operation (hours)** Unadjusted β−0.25−0.70-0.200.28 Adjusted\* β−0.24−0.70-0.220.31 Adjusted\* β excluding referred patients−0.41−0.97-0.150.15**Time to CT (hours)** Unadjusted β−0.32−0.61\--0.030.03 Adjusted\* β−0.01−0.02-0.0040.16 Adjusted\* β excluding referred patients−0.03− 0.08-0.020.22\*Adjusted for age, gender, age\*gender (interaction term), ISS (spline), Revised Trauma Score, Charlson Comorbidity Index, penetrating injury, AIS head injury, referred patients (when not excluded)

Volume-outcome relationship: secondary outcomes {#Sec10}
-----------------------------------------------

There was no association between hospital volume and LOS, also after adjusting for patient characteristics (β = 0.03 per 10 patients, *p* = 0.33, Table [3](#Tab3){ref-type="table"}). There was no association between hospital volume and critical care LOS after adjustment (β = − 0.61 per 10 patients, *p* = 0.78). After excluding referred patients, critical care LOS was associated with hospital volume (β = 0.48 per 10 patients, *p* = 0.04). In the adjusted models there was no association between hospital volume and time to first operation (adjusted β = − 0.24 per 10 patients, *p* = 0.31) or time to first CT scan (adjusted β = − 0.01 per 10 patients, *p* = 0.16).

Discussion {#Sec11}
==========

This study aimed to evaluate whether there was an association between hospital volume and outcomes among severely injured patients in Major Trauma Centres. Despite the large variation in volume of the included MTCs, no relationship between hospital volume and outcome of severely injured patients was found, contrary to current beliefs \[[@CR5]\]. Small between-centre differences for in-hospital mortality were found which suggests comparable outcomes between MTCs.

Centralization of care is suggested to improve cost-effectivity and patient outcomes \[[@CR14], [@CR15]\]. Most evidence for the benefit of regionalization in terms of hospital volume is found in elective surgical procedures \[[@CR16]--[@CR18]\]. It seems logical that severely injured patients could benefit from centralization, because severely injured patients often require complex care, having experience in treating those patients could improve patient outcomes. Over the past decades, centralization on trauma care, based on different criterions, took place showing beneficial outcomes \[[@CR2], [@CR19], [@CR20]\]. MTCs have been established in England in 2012. A before-after study showed no significant improvements in mortality and LOS in the post-implementation analysis (270 days), although the caseload increased \[[@CR3]\]. It is thought that benefits of regionalization will become visible over a number of years \[[@CR21]\] when trauma services "mature" in terms of experience, pre-hospital triage and refinement of hospital systems \[[@CR3], [@CR22], [@CR23]\]. A recent publication shows that the development of Major Trauma Networks including MTCs covering the entire national population increases the odds of survival for patients reaching the hospital alive \[[@CR4]\]. This suggests that centralization without volume requirements shows beneficial results.

There are several explanations for small observed between-centre differences. First, TARN closely monitors MTCs with emphasis on outcomes. TARN provides hospitals with case-mix adjusted survival rates to help hospital clinicians to improve their system of trauma care. Second, MTCs need to fulfil various designation requirements which decreases variation in structure and processes. For example, MTCs must have 24/7 availability of consultants to lead the trauma team and 24/7 availability of fully staffed operating theatres. Also, MTCs are required to create a pathway from the prehospital phase to the rehabilitation phase for each severely injured patient \[[@CR4]\]. To the best knowledge, no other study assessed inter-hospital variation for severely injured patients. Considerable between-centre differences have been found in the field of traumatic brain injury (TBI) \[[@CR6]--[@CR9]\], which were caused by structural differences between countries and centres. The current study showed no evidence for the volume-outcome relationship in severely injured patients treated in MTCs. This is in contrast with a recently published systematic review and meta-analysis which found a beneficial effect for high volume centres \[[@CR5]\]. However, most of these studies included both MTCs and non MTCs, so a potential volume effect could be biased by other factors. A further consideration, most of these studies were performed in the United States which differs in terms of geography, infrastructure and trauma epidemiology compared to the England. England has more densely populated areas, shorter transportation distances, and the already existing infrastructure of district general hospitals providing universal acute care coverage \[[@CR24], [@CR25]\]. The designation criteria for MTCs do not include a hospital volume requirement, so hospital volume differed from 69 to 781 severely injured patients per year \[[@CR26]\]. Therefore, it was possible to assess hospital volume in a linear rather than categorical fashion which provided a more in-depth assessment of centre effects.

Increasing hospital volume was associated with a longer critical care LOS after excluding referred patients. There was no association between hospital volume and critical care LOS when including all severely injured patients. The most evident explanation for the association between hospital volume and critical care LOS is chance. It is also possible that referred patients come after they stayed at the ICU at their referring hospital and therefore have shorter LOS.

Other factors than hospital volume cause the extremely small between-centre differences in MTCs. The most evident explanation is differences in patient characteristics. After adjusting for several demographic and injury severity characteristics, higher hospital volume was not associated with lower mortality. A limitation of this study is that insufficient adjustment of case-mix differences is possible. With use of the TARN model \[[@CR12]\] extended with clinically relevant variables from the TRISS model, adjustments for case-mix differences between MTCs were made. However, the risk of residual confounding cannot be exclude. Also, the results might be influenced by a few very well organized MTCs. It was not possible to assess the relationship between surgeon volume and outcomes. Other studies that investigated this relationship showed inconsistent results \[[@CR5], [@CR27]--[@CR29]\]. The caseload and experience per surgeon might influence between-centre differences. Also, we were unable to assess the health care provider - patient ratio and Critical Care volume bed - availability ratio. Our results are only applicable to MTCs and can thereforenot be generalized to non MTCs with low volumes of severely injured patients. Also, the prehospital network is important for the outcomes of severely injured patients. Detailed prehospital data was not available when doing this study. In order to investigate whether these results can be extrapolated to other trauma systems, it is important to take the prehospital systems into account. Another limitation is the lack of a good definition of the severely injured patient. The universally used injury severity measure in trauma registries and research is ISS, where ISS \> 15 is defined as severely injured. However, questions about the accuracy of ISS have been raised. First, an equal Abbreviated Injury Scale (AIS) in different body regions is assumed to be equal in injury severity \[[@CR30], [@CR31]\]. Second, ISS does not account for multiple injuries in the same body region \[[@CR31], [@CR32]\]. So it is possible that patients with equal ISS scores do not have the same injury severity. Therefore, future research should examine which patient groups really benefit from treatment at a MTC, to make optimal use of the resources and expertise of MTCs. A sensitivity analysis using the NISS \> 15 as severely injured showed no association between hospital volume and outcomes in MTCs.

Conclusions {#Sec12}
===========

Despite a tenfold variation in volume, no differences in outcomes of severely injured patients were found between English MTCs. These results suggest that MTCs in England achieve comparable outcomes in severely injured patients despite the number of severely injured patients they treat. Centres with similar structure and processes of care can achieve comparable outcomes for severely injured patients. Further research is necessary to see whether these results can be extrapolated to trauma systems in other countries.

Appendix {#Sec13}
========

Analyses with NISS\> 15 instead of ISS \> 15 {#Sec14}
--------------------------------------------

Table 4Baseline characteristicsTotal\
*N* = 60,146Age53 (33--74)Male41,435 (68.9%)Penetrating injury2235 (3.7%)ISS21 (16--26)NISS29 (19--40)GCS at arrival Emergency Department15 (13--15)Charlson Comorbidity Index0 (0--3)Intubation at Emergency Department12,961 (21.5%)Hypovolemic shock at Emergency Department (SBP \< 90 mmHg)10,667 (17.7%)AIS head ≥327,850 (46.3%)RTS7.84 (7.7--7.84)Referred patients18,151 (30.1%)Continuous: median (IQR), categorical: N (%), New Injury Severity Score (NISS), Injury Severity Score (ISS), Abbreviated Injury Scale (AIS), Revised Trauma Score (RTS), Glasgow Coma Score (GSC)

Table 5Unadjusted and adjusted coefficients of hospital volume for different outcome measures, expressed as odds ratio or betaOutcomeOR per 10 patients95% CIP-value**In-hospital mortality** Unadjusted OR1.641.04--2.610.03 Adjusted\* OR1.010.64--1.600.96**BetaLength of stay (days)** Unadjusted β0.66−0.15 - 1.470.11 Adjusted\* β0.40− 0.45 - 1.240.34**Critical care length of stay (days)** Unadjusted β−0.02−0.36 -- 0.320.89 Adjusted\* β−0.04−0.32 -- 0.230.76**Time to operation (hours)** Unadjusted β0.004−0.03 - 0.030.97 Adjusted\* β0.005−0.03 -- 0.030.75**Time to CT (hours)** Unadjusted β−0.03−0.05 - -0.010.01 Adjusted\* β−0.003−0.007 - 0.0010.11\*Adjusted for age, gender, age\*gender (interaction term), NISS (spline), Revised Trauma Score, Charlson Comorbidity Index, penetrating injury, referred patients

AIS

:   Abbreviated Injury Scale

AOR

:   Adjusted Odds Ratio

CCI

:   Charlson Comorbidity Index

ISS

:   Injury Severity Score

LOS

:   Length of stay

MTC

:   Major Trauma Centre

OR

:   Odds Ratio

RTS

:   Revised Trauma Score

TARN

:   Trauma Audit and Research Network

TBI

:   Traumatic Brain Injury
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